1. Safavi K, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70:628-33.

2. Olsen EA. Hair disorders. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology In General Medicine, 5th ed. Vol 1. New York: McGraw-Hill. 1999:737-9.

3. Dawber RPR, de Berker D, Wojnarowska F. Disorders of hair. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology, 6th ed. Vol 4. Oxford: Blackwell Science 1998:2919-27.

4. Messenger AG, Simpson NB. Alopecia areata. In: Dawber RPR, ed. Diseases of the Hair and Scalp. Oxford: Blackwell Science 1997:338-69.

5. Muller SA, Winkelmann RK. Alopecia areata. Arch Dermatol 1963;88:290-7.

6. Green J, Sinclair R. Genetics of alopecia areata. Aus J Dermatol 2000;41:213-18.

7. McDonagh AJG, Messenger AG. Alopecia areata. Clin Dermatol 2001;19:141-7.

8. Walker SA, Rothman S. Alopecia areata: a statistical study and consideration of endocrine influences. J Invest Dermatol 1950;14:403-13.

9. Sinclair RD, Banfield CC, Dawber RPR. Handbook of Diseases of the Hair and Scalp. Oxford: Blackwell Science 1999:75-84.

10. van der Steen PHM, van Baar HMJ, Happle R, Boezeman JBM, Perret CM. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991;24:227-30.

11. Weedon D. Diseases of cutaneous appendages. In: Skin Pathology. Edinburgh: Churchill Livingstone 1997:381-424.

12. Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 1973;88:55-9.

13. Porter D, Burton J. A comparison of intralesional triamcinolone hexacetomide and triamcinolone acetonide in alopecia areata. Br J Dermatol 1971;85:272-3.

14. Olsen E, Hordinsky M, McDonald-Hull S et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999;40:242-6.

15. Rokshar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998;39:751-61.

16. Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001;37:1063-8.

17. Tosti A, De Padova MP, Minghetti G, Veronesi S. Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol 1986;15:209-10.

18. Swanson NA, Mitchell AJ, Leahy MS, Headington JT, Diaz LA. Topical treatment of alopecia areata. Arch Dermatol 1981;117:384-7.

19. Daman LA, Rosenberg EW, Drake L. Treatment of alopecia areata with dinitrochlorobenzene. Arch Dermatol 1978;114:1036-8.

20. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.

21. de Prost Y, Paquez F, Touraine R. Dinitrochlorobenzene treatment of alopecia areata. Arch Dermatol 1982; 118:542-5.

22. Shapiro J, Tan J, Ho V, Abbott F, Tron V. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathological evaluation. J Am Acad Dermatol 1993;29:729-35.

23. Tosti A, Bardazzi F, Guerra L. Alopecia totalis: Is treating non-responder patients useful? J Am Acad Dermatol 1991;24:455-6.

24. Charuwichitratana S, Wattanakrai P, Tanrattanakorn S. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0-25% desoximetasone cream. Arch Dermatol 2000;136:1276-7.

25. Pascher F, Kurtin S, Andrade R. Assay of 0-2% fluocinolone acetonide cream for alopecia areata and totalis. Dermatologica 1970;141:193-202.

26. Taylor CR, Hawk JLM. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 1995;133:914-18.

27. Feidler-Weiss VC, Buys CM. Evaluation of anthralin therapy in the treatment of alopecia areata. Arch Dermatol 1987;123:1491-3.

28. Feidler-Weiss VC, West DP, Fu TS et al. Alopecia areata treated with topical minoxidil. Arch Dermatol 1984;120: 457-63.

29. Vanderveen EE, Ellis CN, Kang S et al. Topical minoxidil for hair regrowth. J Am Acad Dermatol 1984;11:416-21.

30. Frentz G. Topical minoxidil for extended areata alopecia. Acta Derm Venereol 1985;65:172-5.

31. Shi Y-P. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia. Arch Dermatol 1986;122:506.

32. Fiedler-Weiss VC. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol 1987;16:745-8.

33. Fiedler-Weiss VC, West DP, Buys CM, Rumsfield JA. Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol 1986;122:180-2.

34. Price V. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol 1987;16:730-6.

35. White SI, Friedmann PS. Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol 1985; 121:591.

36. Vestey JP, Savin JA. A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm Venereol 1986;66:179-80.

37. Feidler VC. Alopecia areata: Current therapy. J Invest Dermatol 1991;96(Suppl.):69.

38. Lei Y, Nie Y-F, Zhang J-M, Liao D-Y, Li H-Y. Effect of superficial hypothermic cryotherapy with liquid nitrogen on alopecia areata. Arch Dermatol 1991;127:1851-2.

39. Hay I, Jamieson M, Ormerod A. Randomized trial of aromatherapy. Arch Dermatol 1998;134:1349-52.

40. Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol 1983;63:49-52.

41. van der Steen PHM, van Baar HMJ, Perret CM, Happle R. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991;24: 253-7.

42. Winter RJ, Kern F, Blizzard RM. Prednisolone therapy for alopecia areata. Arch Dermatol 1976;112:1549-52.

43. Unger WP, Schemmer RJ. Corticosteroids in the treatment of alopecia totalis. Arch Dermatol 1978;114:1486-90.

44. Sharma VK. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996;35:133-6.

45. Gupta AK, Ellis CN, Cooper KD et al. Oral cyclosporin for the treatment of alopecia areata. J Am Acad Dermatol 1990;22:242-50.

46. Davies MG, Bowers PW. Alopecia areata arising in patients receiving cyclosporine immunosuppression. Br J Dermatol 1995;132:827-9.

47. Berth-Jones J, Hutchinson PE. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clin Exp Dermatol 1991;16:172-5.

48. Galbraith GMP, Thiers BH, Jensen J, Hoehler F. A randomised double-blind study of inosiplex (Isoprinosine) therapy in patients with alopecia totalis. J Am Acad Dermatol 1987;16:977-83.

49. Pipoli M, D'Argento V, Coviello C, Dell'Osso A, Mastrolonardo M, Vena GA. Evaluation of topical immunotherapy with squaric acid dibutylester, systemic interferon alpha and the combination of both in the treatment of chronic severe alopecia areata. J Dermatol Treat 1995;6:95-8.

50. Schuttelaar M-LA, Hamstra JJ, Plinck EPB et al. Alopecia areata in children: treatment with diphencyprone. Br J Dermatol 1996;135:581-5.

51. Orecchia G, Malagoli P. Topical immunotherapy in children with alopecia areata. J Invest Dermatol 1995;104(Suppl.):35S-36S.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book

Post a comment